Current Medicinal Chemistry
Title:Meet Our Co-Editor:
Volume: 22 Issue: 34
Author(s): Bernard Pirotte
Affiliation:
Export Options
About this article
Cite this article as:
Pirotte Bernard, Meet Our Co-Editor:, Current Medicinal Chemistry 2015; 22 (34) . https://dx.doi.org/10.2174/092986732234151119150019
DOI https://dx.doi.org/10.2174/092986732234151119150019 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
19
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Molecular and Pharmacological Characterization of Hamster HCA1 and HCA2
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Evaluation of Osteoporosis Risk Associated with Chronic Use of Morphine, Fentanyl and Tramadol in Adult Female Rats
Current Drug Safety Risk and Benefit Profile of Dulaglutide in Established Therapeutic Indication
Current Drug Safety Probiotics Efficacy on Oxidative Stress Values in Inflammatory Bowel Disease: A Randomized Double-Blinded Placebo-Controlled Pilot Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Cognitive Decline as a Consequence of Essential Hypertension
Current Pharmaceutical Design Mutations of the Apolipoprotein A5 Gene with Inherited Hypertriglyceridaemia: Review of the Current Literature
Current Medicinal Chemistry Nanosuspension: A Potential Nanoformulation for Improved Delivery of Poorly Bioavailable Drug
Micro and Nanosystems Insulin and the Blood-Brain Barrier
Current Pharmaceutical Design Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review
Current Vascular Pharmacology Withdrawn: Effect of Fractions of Vernonia amygdalina on Some Biochemical Parameters in High Fat Diet-Induced Obese Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Biological Roles of Ursolic Acid in the Treatment of Human Diseases
Current Bioactive Compounds A Rationale for Inhibiting Progesterone-Related Pathways to Combat Breast Cancer
Current Cancer Drug Targets Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer’s Disease
Current Topics in Medicinal Chemistry Cross-Talking Between PPAR and WNT Signaling and its Regulation in Mesenchymal Stem Cell Differentiation
Current Stem Cell Research & Therapy Peroxisome Proliferator-Activated Receptors, Fatty Acid Oxidation, Steatohepatitis and Hepatocarcinogenesis
Current Molecular Medicine Growth Velocity, Final Height and Bone Mineral Metabolism of Short Children Treated Long Term with Growth Hormone
Current Pharmaceutical Biotechnology A Mini-review on HER2 Positive Breast Cancer and its Metastasis: Resistance and Treatment Strategies
Current Nanomedicine Endothelial Dysfunction: Methods of Assessment & Implications for Cardiovascular Diseases
Current Pharmaceutical Design Secondary Hypertension: The Ways of Management
Current Vascular Pharmacology NF-κB in Type 1 Diabetes
Inflammation & Allergy - Drug Targets (Discontinued)